Investigational Combination Shows Promise in Chronic Hepatitis D

Hepatitis B – A Silent Killer Difficult to Control

Hepatitis is a dangerous inflammation of the liver linked to a variety of infectious viruses and non-infectious agents that can lead to a range of health problems, including severe and potentially fatal liver damage and cancer. Generally, hepatitis falls into five classifications: A, B, C, D, and E. Hepatitis B is of major concern due to its prevalence and the serious complications that accompany this virus type. As reported by Balipost.com, a M…

Investigational Combination Shows Promise in Chronic Hepatitis D

(MedPage Today) — WASHINGTON — An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial. At week 24, the combined response of alanine… Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118381 Author : Publish date : 2025-11-09 23:00:00 Copyright for syndicated content belongs to […] The post Investigational Combination S…